News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
26,096 Results
Type
Article (1146)
Company Profile (3)
Press Release (24947)
Multimedia
Podcasts (3)
Webinars (2)
Section
Business (9666)
Career Advice (15)
Deals (1311)
Drug Delivery (3)
Drug Development (3124)
Employer Resources (2)
FDA (455)
Job Trends (658)
News (13253)
Policy (841)
Tag
2026 Best Places to Work (1)
Academia (63)
Accelerated approval (6)
ADA (3)
Adcomms (1)
Allergies (23)
Alliances (1460)
ALS (38)
Alzheimer's disease (67)
Antibody-drug conjugate (ADC) (63)
Approvals (521)
Artificial intelligence (25)
ASCO (14)
Autoimmune disease (45)
Automation (6)
Bankruptcy (9)
Best Places to Work (619)
BIO (4)
Biologics (2)
BIOSECURE Act (2)
Biosimilars (16)
BioSpace Insights (1)
Biotechnology (4)
Bispecific (1)
Bladder cancer (18)
Brain cancer (2)
Breast cancer (20)
Cancer (399)
Cardiovascular disease (31)
Career advice (14)
Career pathing (1)
CAR-T (18)
CDC (1)
CDMO (7)
Cell therapy (55)
Cervical cancer (4)
Clinical research (3257)
Collaboration (115)
Commercialization (2)
Compensation (110)
Complete response letters (3)
COVID-19 (71)
CRISPR (10)
C-suite (140)
Cystic fibrosis (6)
Data (763)
Depression (12)
Dermatology (15)
Diabetes (37)
Diagnostics (215)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (11)
Drug pricing (1)
Drug shortages (1)
Duchenne muscular dystrophy (8)
Earnings (3720)
Editorial (3)
Employer resources (3)
ESMO (20)
Events (4320)
Executive appointments (113)
FDA (747)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (124)
Gene editing (17)
Generative AI (2)
Gene therapy (41)
GLP-1 (19)
Government (89)
Guidances (30)
Healthcare (634)
Hematology (25)
HIV (15)
Huntington's disease (6)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (3)
Immunology and inflammation (10)
Immuno-oncology (9)
Indications (14)
Infectious disease (99)
Inflammatory bowel disease (9)
Influenza (6)
Intellectual property (21)
Interviews (2)
IPO (582)
Job creations (150)
Job search strategy (11)
JPM (1)
Kidney disease (17)
Labor market (4)
Layoffs (15)
Leadership (1)
Legal (216)
Licensing (6)
Liver cancer (4)
Longevity (1)
Lung cancer (43)
Lung diease (2)
Lymphoma (58)
Machine learning (5)
Management (2)
Manufacturing (61)
Marketing (6)
MASH (37)
Medical affairs (1)
Medical device (337)
Medtech (342)
Melanoma (1)
Mergers & acquisitions (841)
Metabolic disorders (107)
mRNA (2)
Multiple sclerosis (43)
NASH (3)
Neurodegenerative disease (35)
Neuropsychiatric disorders (9)
Neuroscience (240)
NextGen: Class of 2026 (276)
Non-profit (120)
Now hiring (3)
Obesity (30)
Opinion (3)
Ovarian cancer (32)
Pain (16)
Pancreatic cancer (9)
Parkinson's disease (44)
Patents (43)
Patient advocacy (2)
Patient recruitment (53)
Patient selection (6)
Peanut (15)
People (4065)
Peptides (2)
Pharmaceutical (1)
Phase 1 (1015)
Phase 2 (1600)
Phase 3 (1023)
Pipeline (960)
Policy (13)
Postmarket research (27)
Preclinical (340)
Prostate cancer (24)
Psychedelics (11)
Radiopharmaceuticals (40)
Rare diseases (83)
Real estate (218)
Recruiting (1)
Regulatory (907)
Reports (1)
Research institute (85)
Resumes & cover letters (3)
RSV (15)
Schizophrenia (18)
Series A (26)
Series B (14)
Service/supplier (1)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (11)
Sponsored (1)
Startups (289)
Supply chain (5)
Switzerland (3)
The Weekly (3)
Vaccines (62)
Venture capital (6)
Weight loss (12)
Women's health (18)
Worklife (1)
Date
Today (2)
Last 7 days (45)
Last 30 days (224)
Last 365 days (1712)
2026 (1568)
2025 (2094)
2024 (2948)
2023 (1952)
2022 (1488)
2021 (1847)
2020 (1866)
2019 (1376)
2018 (1072)
2017 (922)
2016 (905)
2015 (1136)
2014 (909)
2013 (825)
2012 (813)
2011 (778)
2010 (742)
Location
Africa (15)
Alabama (1)
Arizona (7)
Asia (1404)
Australia (281)
California (1043)
Canada (328)
China (68)
Colorado (75)
Connecticut (63)
Delaware (19)
Europe (3216)
Florida (96)
Georgia (36)
Idaho (2)
Illinois (114)
India (22)
Indiana (48)
Japan (38)
Kansas (1)
Kentucky (2)
Maine (1)
Maryland (70)
Massachusetts (1130)
Michigan (71)
Minnesota (10)
Missouri (2)
Montana (1)
Nevada (11)
New Hampshire (1)
New Jersey (502)
New York (276)
North Carolina (85)
Northern California (459)
Ohio (16)
Oklahoma (1)
Oregon (1)
Pennsylvania (453)
Puerto Rico (5)
South America (17)
Southern California (498)
Tennessee (14)
Texas (108)
United States (4343)
Utah (68)
Virginia (12)
Washington D.C. (1)
Washington State (150)
Wisconsin (17)
26,096 Results for "curia formerly amri".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Curia Expands Fermentation Capacity in León, Spain
November 9, 2026
·
2 min read
Press Releases
Curia Invests $28 Million in Sterile API Manufacturing
October 5, 2026
·
2 min read
Press Releases
Anixa Biosciences and Curia will Develop Final Formulation for Breast Cancer Vaccine in Preparation for Phase 2 Clinical Trial
November 18, 2026
·
5 min read
Press Releases
Curia Expands Glasgow Manufacturing Capacity and Enhances Cell Line Development Platform
March 19, 2026
·
2 min read
Press Releases
Spruce Biosciences Announces Separation of CRHX-101 (Formerly SPR-202) Program into Adrenyx Biosciences
November 9, 2026
·
10 min read
Press Releases
Curia Sterile Drug Product Facility Named Massachusetts Manufacturer of the Year
October 22, 2025
·
2 min read
Press Releases
Arexera Therapeutics, Formerly Atalanta Therapeutics, Unveils New Corporate Identity and Advances Huntington’s Disease Franchise
October 14, 2026
·
6 min read
Business
Curia Appoints Niall Condon to Lead Manufacturing
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced the appointment of Niall Condon as president of its Manufacturing Division, with immediate effect.
August 2, 2022
·
2 min read
Deals
Integrity Bio and LakePharma Become Curia
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced that Integrity Bio and LakePharma, two companies that it acquired last year, have fully transitioned to the Curia brand.
February 14, 2022
·
2 min read
Biotech Bay
Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities
Berkeley Lights, Inc., a leader in digital cell biology, and Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced Curia’s adoption of The Beacon® Optofluidic system and workflows from Berkeley Lights to accelerate and expand its antibody-based drug discovery capabilities.
June 6, 2022
·
4 min read
1 of 2,610
Next